SCHEMBL6003103

SCHEMBL6003103

COC(=O)N(Cc1ccccc1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
ALDH1A1 P00352 1/20 0.57
GLA P06280 1/20 0.57
HTT P42858 1/20 0.57
PAX8 Q06710 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
CHRM2 P08172 3/20 0.55
CHRM1 P11229 3/20 0.55
CHRM3 P20309 3/20 0.55
TRPM8 Q7Z2W7 2/20 0.52
RNF4 P78317 1/20 0.50
TSPO P30536 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9356687 0.83 ALDH1A1 (0.52) ALDH1A1GLAHTTSMN1; SMN2
SCHEMBL28020614 0.83 CHRM1 (0.52) ALDH1A1GLASMN1; SMN2CHRM2CHRM1
SCHEMBL1925076 0.83 ALDH1A1 (0.59) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL6003098 0.82 NPC1 (0.57) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL9623793 0.82 ALDH1A1 (0.47) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL5137574 0.81 ALDH1A1 (0.50) ALDH1A1GLAHTTSMN1; SMN2
SCHEMBL7653262 0.81 ALDH1A1 (0.66) ALDH1A1GLAHTTSMN1; SMN2
SCHEMBL5461474 0.81 NPC1 (0.61) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL1927016 0.81 ALDH1A1 (0.69) NPC1RAB9AALDH1A1GLAHTT
SCHEMBL9363696 0.80 ALDH1A1 (0.48) NPC1RAB9AALDH1A1GLAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed